Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Total 13F shares
-
6,941,169
-
Share change
-
+161,651
-
Total reported value
-
$381,769,809
-
Put/Call ratio
-
150%
-
Price per share
-
$55.00
-
Number of holders
-
165
-
Value change
-
+$9,196,245
-
Number of buys
-
90
-
Number of sells
-
50
Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q4 2024
As of 31 Dec 2024,
IRADIMED CORP - Common Stock (IRMD) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,941,169 shares.
The largest 10 holders included
BlackRock, Inc., Nine Ten Capital Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Copeland Capital Management, LLC, Ranger Investment Management, L.P., DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This page lists
166
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.